The Cigna Group stock gains focus as 2026 earnings outlook rises

The Cigna Group reported stronger third-quarter operating performance on Thursday, November 5, 2026, and raised its full-year adjusted earnings outlook. The Financial Times company announcement said revenue increased 6 percent from the prior-year quarter to 73.7 billion dollars for the three months ended September 30.

Adjusted income from operations was 2.1 billion dollars, or 7.98 dollars per share, compared with 2.1 billion dollars and 7.83 dollars per share a year earlier. Reported shareholders' net income fell to 1.4 billion dollars, or 5.47 dollars per share, from 1.9 billion dollars and 6.98 dollars. The company attributed the decline primarily to the absence of an after-tax gain on a sale that benefited the third quarter of 2025.

Healthcare business drives earnings improvement

Cigna Healthcare was the stronger operating contributor. Adjusted revenue in the segment rose 9 percent to 11.7 billion dollars, while pretax adjusted income from operations increased 15 percent to 1.2 billion dollars. The company linked the improvement primarily to higher net investment income and better operating efficiency.

The segment's medical care ratio was 85.0 percent, compared with 84.8 percent a year earlier. For the full year, management narrowed its expected range to 84.2 percent plus or minus 25 basis points, while raising the segment's pretax adjusted earnings floor by 50 million dollars to 4.6 billion dollars.

Evernorth Health Services generated adjusted revenue of 63.8 billion dollars, up 6 percent from the prior-year quarter. Pretax adjusted income from operations declined 4 percent to 1.8 billion dollars. Within the segment, Specialty and Care Services earnings increased 15 percent to 1.1 billion dollars, while Pharmacy Benefit Services earnings declined amid client contract renewals and strategic investments.

Guidance points to continued execution

The Cigna Group now expects consolidated adjusted income from operations of at least 30.60 dollars per share for 2026, an increase of 0.15 dollars from its prior projection. The outlook includes anticipated dividends and future share repurchases. Evernorth's full-year pretax adjusted earnings target remains at least 6.9 billion dollars.

Chief Executive Officer Brian Evanko said the company was advancing its Accelerate to One modernization and productivity initiative while pursuing core growth and more personalized healthcare services. The release also said Cigna had repurchased 1.8 million shares for approximately 500 million dollars through November 4.

The Cigna Group stock traded at 263.45 euros on Lang & Schwarz at 12:40 CET on Tuesday, November 10, 2026.

US equities remain linked to developments around the S&P 500, which provides the broader market backdrop for large healthcare companies.

More news and analyses on The Cigna Group stock